Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 449-160-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03 Apr 2001 - 04 Jul 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- other: mammalian erythrocyte micronucleus test (migrated information)
Test material
- Reference substance name:
- -
- EC Number:
- 449-160-7
- EC Name:
- -
- Cas Number:
- 116912-64-2
- Molecular formula:
- C7H18N2O4Si C8H20N2O4Si C9H22N2O4Si C10H24N2O4Si
- IUPAC Name:
- [3-(ethoxydimethoxysilyl)propyl]urea; [3-(trimethoxysilyl)propyl]urea; {3-[diethoxy(methoxy)silyl]propyl}urea
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Age at study initiation: 8-10 weeks
- Weight at study initiation: Males: 27.4 – 31.0 g; Females: 24.6 – 29.0 g
- Assigned to test groups randomly: yes
- Fasting period before study: no
- Housing: five per sex per polycarbonate cage
- Diet: standard pelleted laboratory diet (Altromin, code VRF-1, Lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 3
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Test substance was given undiluted.
- Duration of treatment / exposure:
- Not applicable
- Frequency of treatment:
- Single treatment
- Post exposure period:
- 24 and 48 h after treatment
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5 per sex per dose at any sampling time point
- Control animals:
- other: yes (0.9% NaCl)
- Positive control(s):
- - cyclophosphamide
- Justification for choice of positive control(s): none given in report - standard control
- Route of administration: by oral gavage
- Doses / concentrations: 50 mg salt/kg bw
Examinations
- Tissues and cell types examined:
- Bone marrow smear of the femurs (polychromatic erythrocytes with and without micronucleus, normochromatic erythrocyes)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: Based on a range finding assay in 4 animals with a dose of 2000 mg/kg bw
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields):
500, 1000, 2000 mg/kg bw: 24 h post-dose
2000 mg/kg bw: 48 h post-dose
DETAILS OF SLIDE PREPARATION: cells were washed, resuspended, fixed on glass slides with methanol, stained using the "Wright-stain procedure"
METHOD OF ANALYSIS: light microscope - area selected at x100, analysis performed at x 1000
2000 PCEs scored for presence of micronuclei. The ratio of PCE to NCEs, ( normochromatic erythrocytes) was determined by counting and differentiating the first 1000 erythrocytes.
- Evaluation criteria:
- The test article would have been considered to induce a positive response if a biologically and statistically significant increase in the frequency of micronucleated polychromatic erythrocytes is observed at one or more doses (Wilcoxon Rank Sum Test, two-sided test at p≤ 0.05) at any sampling time in the combined data for both sexes or in the male or female animals separately.
The test article was judged negative if no statistically significant increase in micronucleated polychromatic erythrocytes above the concurrent vehicle control values was observed at any sampling time. - Statistics:
- Wilcoxon Rank Sum Test
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 2000 mg/kg bw
- Clinical signs of toxicity in test animals: no abnormalities were observed within 3 days.
- Evidence of cytotoxicity in tissue analyzed: no abnormalities were observed.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: no induction was observed.
- Ratio of PCE/NCE: No change of the ratio was observed after treatment with test substance. A decrease of the PCE/NCE ratio was observed after treatment with CP.
Any other information on results incl. tables
Summary of results of bone marrow micronuleus analysis following single ip administration
Treatment (10 ml/kg bw) |
Sex |
Time (hr) |
No. of animals |
PCE/total erythrocytes |
Micronuclei/1000 PCE |
0.9% NaCl |
M |
24 |
5 |
1.00 ± 0.06 |
1.2 ± 1.6 |
|
F |
24 |
5 |
1.02 ± 0.04 |
3.8 ± 0.8 |
500 |
M |
24 |
5 |
0.96 ± 0.05 |
1.6 ± 1.8 |
|
F |
24 |
5 |
0.93 ± 0.01 |
2.4 ± 1.8 |
1000 |
M |
24 |
5 |
0.98 ±0.08 |
0.8 ± 1.1 |
|
F |
24 |
5 |
0.99 ± 0.07 |
1.6 ± 1.1 |
2000 |
M |
24 |
5 |
0.98 ± 0.07 |
2.6 ± 1.5 |
|
F |
24 |
5 |
0.96 ± 0.04 |
1.6 ± 1.8 |
Positive control |
M |
48 |
5 |
0.53 ± 0.11 |
*23.8 ± 9.3 |
|
F |
48 |
5 |
0.408 ± 0.01 |
*18.0 ± 4.2 |
2000 |
M |
48 |
5 |
0.99 ± 0.04 |
3.8 ± 3.6 |
|
F |
48 |
5 |
0.98 ± 0.06 |
2.2 ± 1.9 |
*Statistically significant increase, p < 0.05
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Ureidopropyltrialkoxysilane, mixed methoxy and ethoxy esters has been tested according to OECD 474 and under GLP conditions. No significant increase in the incidence of micronucleated polychromatic erythrocytes was observed in the bone marrow of male or female rats 24 or 48 hours after a single oral dose of up to and including 2000 mg/kg bw. A reduction in the PCE/total erythrocyte ratio was only observed in the 48 hour positive control group. It is concluded that the test substance is negative for the induction of micronuclei under the conditions of the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.